TGFβ1 is a main factor inducing immunosuppression in tumor microenvironment of pancreatic cancer, and inhibition of TGFβ1 strategy may provide a new opportunity for the treatment of pancreatic cancer (36). This evidence concerns the gene TGFB1 and familial pancreatic carcinoma.